About the Report
Transport of liquids, together with nutrients and medications for patient in a controlled quantity is done through IV tubing sets and accessories. Development of this market is majorly boosted by rising adoption of new technologies; for example, sifted IV tubing sets with flow regulators come with a few advantages such as accurate and precise drug delivery, faster results, and improved medication. Moreover, rising patient pool with chronic pain and diabetes is expected to drive demand for IV tubing sets and accessories.
Additionally, there has been an increase in the prevalence of coronary artery diseases (CAD) worldwide, with cardiac arrest being the main reason of death among people above 60 years of age. Globally, in order to maintain their market position, leading companies are acquiring others who are facing large number of product recalls. Favourable reimbursement policies and increasing healthcare expenditure are also some factors driving market expansion.
A latest revised report by Persistence Market Research details the trends in 20+ high growth markets, along with the impact the COVID-19 pandemic has had on the healthcare industry in general, and on the demand for IV tubing sets and accessories in particular.
Find Out More about the Report Coverage
- Baxter International Inc.
- Hospira Inc. (Pfizer Inc.)
- Becton, Dickinson Company (CareFusion)
- B. Braun Melsungen AG
- Fresenius Kabi AG
- Smiths Medical
- C.R. Bard, Inc.
- ICU Medical Inc.
- Zyno Medical
- Nipro Corporation
- Poly Medicure Ltd.
Historical Trends Vs. Future Market Outlook
Rising geriatric population is expected to drive demand for IV tubing sets and accessories, since people aged above 60 years are at a high risk of developing cancer. Rising incidence of cancer along with increasing adoption of treatment will provide abundant opportunities for IV tubing sets and accessories manufacturers through the forecast period.
According to Persistence Market Research’s analysis, the IV tubing sets and accessories market is projected to progress at a CAGR of close to 5% from 2021 to 2031.
Customize this Report
Explore Intelligence Tailored to Your Business Goals.
How is increasing prevalence of chronic infections boosting sales of IV tubing sets and accessories?
Rising occurrence of chronic infections, for example, diabetes and cancer, have brought about innovation and introduction of cutting-edge IV tubing sets to be utilized in infusion treatment for effective treatment techniques. This is attributable to better medical services and more increased awareness with regard to economic treatments including high usage of IV tubing sets
Occurrence rate of a few infection conditions such as chronic diseases and respiratory diseases is rising at a disturbing rate in emerging and developing nations, accordingly driving interest for infusion. Populated nations have high prevalence and incidence of chronic illnesses - stroke, which, as a result, is driving the need for infusion therapy, and thereby, IV tubing sets.
Market Research Methodology - Perfected through Years of Diligence
A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.
What is the impact of growing export-import activities in IV tubing sets?
Rising export and import of infusion pumps, supplies, and consumables in nations such as the United Kingdom, France, Poland, Russia, and the Netherlands is expected to help the development of the European market for IV tubing sets and accessories.
The European market offers vast opportunities for exporters of infusion pumps and consumables (including IV tubing sets) within the region, with the U.K., Poland and Russia being major countries to target in order to enhance revenue generation. In Europe, France and Germany offers a huge market for infusion sets and pumps, and have set up many new manufacturing facilities.
Explore Persistence Market Research’s expertise in promulgation of the business !
How is rising adoption of branded products impacting the market?
Over the recent years, rise in interest for patented and branded advanced IV tubing sets and related IV tubing sets has been seen from end users such as ambulatory surgical centres, hospitals, homecare settings, and long-term care in Europe, when contrasted with the Asia Pacific locale.
Nations in APAC seek cost-effective IV tubing sets and accessories, and depend significantly on locally manufactured devices. Nonetheless, in regions such as Europe and North America, end users can afford cost-intensive products that offer quality and safety output. Additionally, branded items, especially IV tubing sets with flow regulators are expensive.
How big is the opportunity in the U.S. for IV tubing sets and accessories?
The medical services system of the U.S. is well-known for its high level expenditure and infrastructure. The system of hospitals and care centers is known for administrative principles and insurance strategies. Government and administrative bodies in the U.S. are embracing a few expense control intends to lessen medical care expenditure.
The move from a volume- to a cost-based system is significantly determined by different measures attempted by suppliers, governments, insurance payers, and biotechnology organizations. A portion of the actions are result-based benefits, valuing, hazard sharing, serious offering, and value control. A worth-based medical services system won't just give improved results through incorporated care pathways, but additionally demand valuing tension on medical device organizations, and this is probably going to affect funds on the R&D of cutting-edge clinical therapy advances.
The market in the U.S. is expected to progress at a sound CAGR of more than 4% during the estimate time frame.
How is rising number of infectious disease in Germany influencing demand for IV tubing sets and accessories?
Rising number of chronic diseases is pushing IV tubing sets and accessories interest in Germany. The Robert Koch Institute (RKI), a German research institute and government organization, which is liable for infectious control and prevention, as per the German Protection against Infection Act, records and examines information on the event of various diseases in Germany. Every year, outcomes are printed in the Epidemiological Yearbook of the Notifiable Infectious Diseases.
Information shows expanded rates of a large number of chronic diseases, including, but restricted to, measles, meningococcal meningitis, typhus tuberculosis, leprosy, HIV/AIDS malaria, whooping cough, and syphilis. It is noted, nonetheless, a large portion of additional tropical diseases that entered the country from Africa was controlled and there were no large episodes among everyone. In any case, expanded instances of chronic diseases is expected to bolster demand for IV tubing sets and accessories in Germany.
What is the Impact of increasing geriatric population of China on IV tubing sets and accessories demand?
China is one of the most populated countries on the planet, confronting the fast aging of its populace. As per information from China's National Bureau of Statistics, toward the end of 2018, 11.9 percent of the population (166.6 million individuals) were 65 or more elder. China's elderly emergency is well in progress.
China has received different plans to manage the aging populace, including building and improving wellbeing and clinical systems for the elderly, empowering family care joined with social consideration, advancing adaptable retirement, and relaxing birth strategy.
Rising geriatric populace is probably going to fuel demand for IV tubing sets and accessories in the country. More the elder population, more is the occurrence of chronic diseases, which increases the need for surgical procedures and demand for IV tubing sets and accessories.
How are government initiatives boosting sales of IV tubing sets and accessories in India?
Increasing government programs to provide affordable and quality healthcare are expected to complement growth of India's biopharma as well as IV tubing sets and accessories market. High adoption of surgeries to treat chronic diseases such as diabetes, cancer, lung diseases, and others in India also fuels demand for IV tubing sets and accessories.
Moreover, India is also considered as one of the top countries with infectious diseases in the world, increasing the need for IV tubing sets and accessories in the country. Increasing patient pool due to rise in population, emergence of new diseases, and lifestyle changes are also boosting demand for biopharmaceuticals, which is expected to provide high opportunity for providers of IV tubing sets and accessories.
What’s the market share of primary IV tubing sets?
Primary IV tubing sets are expected to hold the highest share, as the tubing sets have an effective and rapid way to deliver drugs and liquids to patients. These tend to be utilized in a few cases such as specialized medication delivery, dehydration, and electrolyte imbalances.
These tubing sets are presented in the patient's body utilizing catheters, which are then bolted with a male Luer lock, permitting smooth delivery of liquids. These are utilized to build the length of primary infusion set and are accessible in an assortment of configurations. The extensive usage of primary IV tubing sets is the main factor advancing segment development.
Why does peripheral intravenous catheter insertion hold a high market share?
The peripheral intravenous catheter insertion segment is expected to contribute maximum revenue share to the global market. In terms of revenue, hospitals accounted for around 40% share in 2020.
These catheters allow the presentation of fluids, blood products, and medications straight into the cardiovascular system, and facilitate quick retention by target organs. This strategy is an intrusive methodology and requires an aseptic procedure for inclusion. Rising awareness among individuals with respect to this methodology and wide scope of availability are expected to support segment development over the estimate time frame.
What is the impact of COVID-19 on the market?
Due to this unprecedented COVID-19 pandemic scenario, the healthcare sector has been the central point to consider its impacts. As importing was halted, it adversely affected the finances of a majority of healthcare companies. Every industry, including healthcare, is suffering from a supply chain crisis.
On the other hand, the good part is that governments and business owners have started looking for alternatives, and this can benefit lower economies to source materials. Also, COVID-19 has compelled businesses and investors across the world to reconsider their own growth strategies and expertise.
On the other side of the COVID-19 crisis, there has been a notable adverse impact on the medical device market, including IV tubing sets and accessories, due to the shortage of manpower and increasing focus of manufacturers on investing in COVID products. Several infusion therapy businesses have been affected significantly, which is having a direct impact on the growth of the market for IV tubing sets and accessories.
Companies are constantly launching new products in the market. Furthermore, companies are striving hard to develop and achieve regulatory approvals for new procedures and interventions.
- For instance, in October 2018, CIVCO Radiotherapy announced FDA Clearance and CE Mark for the Solstice SRS immobilisation system. The Solstice SRS immobilisation system offers unique corrective pitch capability and positioning flexibility.
Given the consolidation in the market, bigger players are focusing on increasing collaborations with other market players.
Some of the leading companies operating in the market are:
- Baxter International Inc.
- Hospira Inc. (Pfizer Inc.)
- Becton, Dickinson Company (CareFusion)
- B. Braun Melsungen AG
- Fresenius Kabi AG
- Smiths Medical (Smiths Group plc.)
- C.R. Bard, Inc.
- Best Medical International Inc
*The list is not exhaustive, and only for representational purposes. Full competitive intelligence with SWOT analysis available in the report.
Scope of Report
Historical Data Available for
USD Million for Value
Key Regions Covered
Key Countries Covered
Key Segments Covered
Key Companies Profiled
Customization & Pricing
Available upon Request
Market by Category
- Primary IV Tubing Sets
- Macro-drip IV Sets
- Micro-drip IV Sets
- Secondary IV Tubing Sets
- Extension IV Tubing Sets
- IV Infusion Set with Flow Regulator
- Filtered IV Tubing Sets
- Non-vented IV Tubing Sets
- Vented IV Tubing Sets
- IV Tubing Accessories
By Age Group
- IV Tubing Sets and Accessories for Paediatric Use
- IV Tubing Sets and Accessories for Adult Use
- IV Tubing Sets and Accessories for Geriatric Use
- Peripheral Intravenous Catheter Insertion
- Central Venous Catheter and Placement
- PICC Line Insertion
By End User
- Ambulatory Surgical Centers
- Specialized Clinics
- Skilled Nursing Facilities
- Long Term Care Centers
- North America
- Latin America
- South Asia
- East Asia
Key Questions Answered in Report
- Which is the most lucrative market for IV tubing sets and accessories?
The U.S. currently leads the global market for IV tubing sets and accessories. Sales in the U.S will be around 30% of the world over the forecast period.
- Which is the top-selling IV product?
Primary IV tubing sets are highly sought-after in every market. Demand for chairs is expected to remain high in the near future, especially due to rising surgical procedures.
- For which application is IV tubing sets and accessories mostly used?
Peripheral intravenous catheter insertion continues to remain the leading application segment. Rising awareness among individuals with respect to this methodology and wide scope of availability are expected to support segment development over the estimated time frame.
- Which are some of the leading companies offering IV tubing sets and accessories?
Some of the leading companies manufacturing IV tubing sets and accessories are Baxter International Inc., Hospira Inc. (Pfizer Inc.), Becton, Dickinson Company (CareFusion, B. Braun Melsungen AG, Fresenius Kabi AG, Smiths Medical (Smiths Group plc.), and Best Medical International Inc.
Enquiry before Buying
- Is this research conducted by Persistence Market Research?
Yes, the research has been conducted by expert analysts of Persistent Market Research, through a combination of primary research and secondary research. To know more about how the research was conducted, you can speak to a research analyst.
- What research methodology is followed by Persistence Market Research?
Persistence Market Research follows a methodology that encompasses the demand-side assessment of the market and triangulates the same through supply-side analysis. This methodology is based on the use of standard market structure, methods and definitions. Request a detailed methodology.
- Who are the respondents for primary research?
Persistence Market Research speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, and industry experts. For a full list of primary respondents, please reach out to us.
- What are the sources of secondary research?
Persistence Market Research conducts extensive secondary research through proprietary databases, paid databases, and information available in the public domain. We refer to industry associations, company press releases, annual reports, investor presentations, and research papers. More information about desk research is available upon request.
- Is a sample of this report available for evaluation?
Yes, you can request a sample, and it will be sent to you through an email.
- How can I buy this report?
Persistence Market Research provides a secure online payment system to buy reports seamlessly. You can buy the report securely and safely.